Discover more insights into Ligand 1 リガンド1

Ligand 1 sentence examples within programmed cell death



Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer


Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves’ Disease and Hashimoto’s Thyroiditis in Korean Patients

Ligand 1 sentence examples within immune checkpoint inhibitor



A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma


Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma

Ligand 1 sentence examples within programmed death 1



Commentary: Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients


Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05



Ligand 1 sentence examples within anti programmed death



Systematic review of combinations of targeted or immunotherapy in advanced solid tumors


B16 melanoma control by anti-PD-L1 requires CD8+ T cells and NK cells: application of anti-PD-L1 Abs and Trp2 peptide vaccines

Ligand 1 sentence examples within anti programmed cell



Durvalumab Plus Tremelimumab in Solid Tumors: A Systematic Review


How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update

Ligand 1 sentence examples within non small cell



First-Line Nivolumab Plus Ipilimumab vs Chemotherapy in Advanced Non-Small Cell Lung Cancer With Tumor PD-L1 ≥ 1%: Patient-Reported Outcomes From CheckMate 227 Part 1.


Relevance of PD-L1 Non-Coding Polymorphisms on the Prognosis of a Genetically Admixed NSCLC Cohort

Ligand 1 sentence examples within epidermal growth factor



EGFR mutation status in non-small cell lung cancer receiving PD-1/PD-L1 inhibitors and its correlation with PD-L1 expression: a meta-analysis


Pulmonary Lymphoepithelioma-Like Carcinoma Treated with Immunotherapy or Chemotherapy: A Single Institute Experience

Ligand 1 sentence examples within tumor necrosis factor



Resveratrol ameliorates toxic effects of cadmium on placental development in mouse placenta and human trophoblast cells.


Sustained peripheral immune hyper-reactivity (SPIHR): an enduring biomarker of altered inflammatory responses in adult rats after perinatal brain injury

Ligand 1 sentence examples within tumor mutational burden



[Blood-based Biomarkers in the Immune Checkpoint Inhibitor Treatment in 
Non-small Cell Lung Cancer].


Dramatic Response to Pembrolizumab Monotherapy in a Patient With ARID1A-Mutant Lung Adenocarcinoma: Case Report.

Ligand 1 sentence examples within lymphocyte antigen 4



Expression of immune checkpoint molecules in Iraqi acute myeloid leukemia patients


TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma

Ligand 1 sentence examples within lymphocyte associated protein



T follicular helper cells: linking cancer immunotherapy and immune-related adverse events


Immunotherapy revisited

Ligand 1 sentence examples within tumor infiltrating lymphocyte



Noninvasive evaluation of tumor immune microenvironment in patients with clear cell renal cell carcinoma using metabolic parameter from preoperative 2-[18F]FDG PET/CT


The Association of Tumor-Infiltrating Lymphocytes and Programmed Cell Death 1 Expression with the Incidence of Distant Metastasis in Triple-Negative Breast Cancer Subjects in Sanglah General Hospital, Bali, Indonesia

Ligand 1 sentence examples within combined positive score



PD-L1 evaluation in head and neck squamous cell carcinoma: Insights regarding specimens, heterogeneity and therapy.


Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Antibody

Ligand 1 sentence examples within programmed death receptor



Expression of Programmed Death Receptor 1 (PD-1) Gene and Its Ligand (PD-L1) in Patients with Laryngeal Cancer


Прогностические биомаркеры эффективности иммунотерапии злокачественных новообразований ингибиторами контрольных точек иммунного ответа

Ligand 1 sentence examples within transforming growth factor



T-Cell-Derived Nanovesicles for Cancer Immunotherapy.


TGF-β and CCL18 as indicators for predicting and monitoring the development of pulmonary fibrosis in patients with COVID-19

Ligand 1 sentence examples within tumor mutation burden



Recurrent undifferentiated embryonal sarcoma of the liver in adult patient treated by pembrolizumab: A case report


Development and validation of a robust immune-related risk signature for hepatocellular carcinoma

Ligand 1 sentence examples within tumor proportion score



Dramatic, significant metabolic response to a one-time pembrolizumab treatment following a relapse of pre-existing organizing pneumonia in a patient with advanced non-small cell lung cancer: A case report.


Rapid-onset and fatal pneumonitis from trametinib treatment of non-small cell lung cancer: A case report

Ligand 1 sentence examples within immune checkpoint protein



Relationship between PD-L1 Expression and Tumor-Infiltrating Lymphocytes in Canine Mammary Tumor


Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy

Ligand 1 sentence examples within immune checkpoint molecule



KPNB1 Inhibitor Importazole Reduces Ionizing Radiation-Increased Cell Surface PD-L1 Expression by Modulating Expression and Nuclear Import of IRF1.


N6-Methyladenosine-Related lncRNAs As Potential Biomarkers For Predicting The Prognoses And Immune Responses In Patients With Cervical Cancer

Ligand 1 sentence examples within motif chemokine ligand



Immune markers are associated with cognitive performance in a multiethnic cohort: The Northern Manhattan Study


TNFα Triggers an Augmented Inflammatory Response in Brain Neurons from Dahl Salt-Sensitive Rats Compared with Normal Sprague Dawley Rats.

Ligand 1 sentence examples within triple negative breast



Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer.


Tumor-derived microparticles promote the progression of triple-negative breast cancer via PD-L1-associated immune suppression.

Ligand 1 sentence examples within advanced non small



Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50%: Results of a Retrospective Study


[Evaluation of Response to Immune Checkpoint Inhibitor Monotherapy or 
Combination with Chemotherapy for Patients with Advanced Non-small Cell Lung Cancer and High PD-L1 Expression].

Ligand 1 sentence examples within high programmed death



[A Real-world Study on the Assessment of Pathological Characteristics and Targeted Therapeutic Effect of Non-small Cell Lung Cancer Patients with Positive Driving Genes and High PD-L1 Expression].


Complete remission of advanced lung adenocarcinoma with first-line pembrolizumab monotherapy: Two case reports

Ligand 1 sentence examples within „ programmed cell



Entwicklungen in der medikamentösen Therapie des triple-negativen Mammakarzinoms


Checkpoint-Inhibitoren bei Hodgkin-Lymphom

Ligand 1 sentence examples within programmed death protein



A snapshot of the PD-1/PD-L1 pathway


Difference in the distribution of tumor‐infiltrating CD8+ T cells and FOXP3+ T cells between micronodular thymoma with lymphoid stroma and micronodular thymic carcinoma with lymphoid stroma

Ligand 1 sentence examples within targeting programmed cell



Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma.


Mouse Preclinical Cancer Immunotherapy Modeling Involving Anti-PD-1 Therapies Reveals the Need to Use Mouse Reagents to Mirror Clinical Paradigms

Ligand 1 sentence examples within tumor immune microenvironment



A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes


Multi-Omics Perspective Reveals the Different Patterns of Tumor Immune Microenvironment Based on Programmed Death Ligand 1 (PD-L1) Expression and Predictor of Responses to Immune Checkpoint Blockade across Pan-Cancer

Ligand 1 sentence examples within tumor programmed death



Real-world outcomes of immunotherapy-based regimens in first-line advanced non-small cell lung cancer.


Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study

Ligand 1 sentence examples within immune checkpoint blockade



Renal Clearable Ultrasmall Single-Crystal Fe Nanoparticles for Highly Selective and Effective Ferroptosis Therapy and Immunotherapy.


Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancers

Ligand 1 sentence examples within programed cell death



PD-L1 and TP-53 mRNA and microRNAs Expression in Liquid Biopsy of NSCLC Patients.


Diagnostic Utility of PD-L1 and TP-53 mRNA As Well As microRNAs Expression in Liquid Biopsy of NSCLC Patients – Pilot Study

Ligand 1 sentence examples within progression free survival



Overview of recent advances in metastatic triple negative breast cancer


Real-world outcomes in locally advanced or metastatic urothelial carcinoma following platinum and PD-1/L1 inhibitor therapy.

Ligand 1 sentence examples within positron emission tomography



Human in vivo neuroimaging to detect reprogramming of the cerebral immune response following repeated systemic inflammation


The Value of 18F-FDG PET/CT in Predicting the Response to PD-1 Blocking Immunotherapy in Advanced NSCLC Patients with High-Level PD-L1 Expression.

Ligand 1 sentence examples within express programmed death



Alveolar Macrophages Inherently Express Programmed Death-1 Ligand 1 for Optimal Protective Immunity and Tolerance


Comment on: A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma

Ligand 1 sentence examples within 1 programmed death



Molecular Dynamics Simulation to Investigate the Blockade Mechanism of Anti-PD-1 Antibody Toripalimab


PD-1 and PD-L2: Do they have prognostic value in lymphomas?

Ligand 1 sentence examples within first line treatment



Prognostic impact of KRAS mutation status for patients with stage IV adenocarcinoma of the lung treated with first-line pembrolizumab monotherapy.


First-Line Treatment Options for PD-L1–Negative Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis

Ligand 1 sentence examples within targeting programmed death



Rolling microneedle electrode array (RoMEA) empowered nucleic acid delivery and cancer immunotherapy


Extracellular and nuclear PD-L1 in modulating cancer immunotherapy.

Ligand 1 sentence examples within transmembrane domain containing



Silencing of CMTM6 Inhibits the Proliferation and Migration of SiHa Cervical Cancer Cells by Inhibiting MAPK Signaling


CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer

Ligand 1 sentence examples within squamous cell carcinoma



Case Report: Squamous Cell Carcinoma of Pancreas With High PD-L1 Expression: A Rare Presentation


Distinct prognostic values of programmed death-ligand 1 and programmed cell death protein 1 in lung adenocarcinoma and squamous cell carcinoma patients.

Ligand 1 sentence examples within immune checkpoint programmed



MiR-200c-3p maintains stemness and proliferative potential in adipose-derived stem cells by counteracting senescence mechanisms


Human Herpesvirus and the Immune Checkpoint PD-1/PD-L1 Pathway: Disorders and Strategies for Survival

Ligand 1 sentence examples within neck squamous cell



CMTM4 regulates epithelial–mesenchymal transition and PD‐L1 expression in head and neck squamous cell carcinoma


Longitudinal assessment of PD-L1 expression and gene expression profiles in patients with head and neck cancer reveals temporal heterogeneity.

Ligand 1 sentence examples within immune checkpoint inhibition



Outlook into the future of front-line immune checkpoint inhibition in metastatic urothelial carcinoma


Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT).

Ligand 1 sentence examples within ligand programmed death



Notch signaling inhibitor and anti-PD-L1 antibody combination therapies decelerate tumor progression in pancreatic cancer


MUC3A induces PD-L1 and reduces tyrosine kinase inhibitors effects in EGFR-mutant non-small cell lung cancer

Ligand 1 sentence examples within non‐small cell lung



Asthma caused by durvalumab after chemoradiotherapy in two patients with non‐small cell lung cancer


Analysis of Real‐World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death‐1 and Programmed Cell Death‐Ligand 1 Inhibitors in Advanced Non‐Small Cell Lung Cancers

Ligand 1 sentence examples within motif ligand 2



POS1365 ANNALYSIS OF PRO-INFLAMMATORY BIOMARKERS IN A POLYMYALGIA RHEUMATICA COHORT DURING THE ACUTE ONSET OF THE DISEASE


SUR1, newly expressed in astrocytes, mediates neuropathic pain in a mouse model of peripheral nerve injury

Ligand 1 sentence examples within expressed programmed death



An autopsy case study of lymphocytic hypophysitis induced by nivolumab treatment for esophageal malignant melanoma.


Lymphoepithelioma-like Intrahepatic Cholangiocarcinoma Is a Distinct Entity With Frequent pTERT/TP53 Mutations and Comprises 2 Subgroups Based on Epstein-Barr Virus Infection

Ligand 1 sentence examples within human epidermal growth



Systematic insight into the active constituents and mechanism of Guiqi Baizhu for the treatment of gastric cancer


[Mass spectrometry imaging technology and its application in breast cancer research].

Ligand 1 sentence examples within low programmed death



Targeting the CSF1/CSF1R Axis is a Potential Treatment Strategy for Malignant Meningiomas.


The best regimens for chemo-naïve incurable non-squamous non-small cell lung cancer with a programmed death-ligand 1, tumor proportion score 1-49%: a network meta-analysis.

Ligand 1 sentence examples within antibodies targeting programmed



Post-translational regulations of PD-L1/PD-1: Mechanisms and opportunities for combined immunotherapy.


Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti–PD-1 Therapy

Ligand 1 sentence examples within soluble programmed death



Serum levels of inhibitory costimulatory molecules and correlations with levels of innate immune cytokines in patients with pulmonary tuberculosis


Soluble Programmed Death-Ligand 1 (sPD-L1) as a Novel Biomarker for the Combination of Anti-PD-L1 Antibody and Radiotherapy for Glioma Patients.

Ligand 1 sentence examples within human programmed death



A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids